SCHEMBL30199561

SCHEMBL30199561

c1ccc(COc2ccc3c(c2)CNCC3)nc1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SYK P43405 6/20 0.56
CD274 Q9NZQ7 1/20 0.48
HRH3 Q9Y5N1 2/20 0.48
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
PNMT P11086 2/20 0.43
MAOA P21397 1/20 0.43
PARP10 Q53GL7 1/20 0.43
CD44 P16070 1/20 0.42
MAOB P27338 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29098117 1.00 SYK (0.56) SYKCD274HRH3KDM4EALDH1A1
SCHEMBL29098064 0.85 HRH3 (0.46) SYKCD274HRH3ADRA2AADRA2B
SCHEMBL30199461 0.85 HRH3 (0.46) SYKCD274HRH3ADRA2AADRA2B
SCHEMBL17712567 0.82 NPC1 (0.55) HRH3KDM4EALDH1A1SMN1; SMN2MAOA
SCHEMBL15897864 0.81 MAOA (0.47) SYKHRH3KDM4EALDH1A1SMN1; SMN2
SCHEMBL3503754 0.81 HRH3 (0.59) CD274HRH3PNMTMAOAMAOB
SCHEMBL29474892 0.81 HRH3 (0.59) CD274HRH3PNMTMAOAMAOB
Hydrochloric Acid SCHEMBL29052776 0.80 HRH3 (0.58) CD274HRH3PNMTMAOAMAOB
Hydrochloric Acid SCHEMBL30515385 0.80 HRH3 (0.58) CD274HRH3PNMTMAOAMAOB
SCHEMBL23537837 0.80 HRH3 (0.46) SYKCD274HRH3ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115594669-B Parallel ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司 2024-11-05 CN disclosed
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 CN disclosed